Anzeige
Mehr »
Login
Samstag, 02.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Technischer Ausbruch: Diese Kupferaktie ist in den letzten 52 Wochen um 300 % gestiegen! Der Durchbruch läuft!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EJL7 | ISIN: US74907L3006 | Ticker-Symbol: 2EB
Lang & Schwarz
02.11.24
09:00 Uhr
0,740 Euro
0,000
0,00 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
QUOIN PHARMACEUTICALS LTD ADR Chart 1 Jahr
5-Tage-Chart
QUOIN PHARMACEUTICALS LTD ADR 5-Tage-Chart
RealtimeGeldBriefZeit
0,7400,74009:00

Aktuelle News zur QUOIN PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoQuoin Pharmaceuticals erhält Fristverlängerung für Nasdaq-Listung1
DoQuoin Pharmaceuticals, Ltd. - 8-K, Current Report1
DoQuoin Pharmaceuticals, Inc.: Quoin Pharmaceuticals to Announce Third Quarter 2024 Financial Results on Thursday, November 7, 20242
22.10.Quoin Pharmaceuticals expands UK clinical trials for rare disease4
30.09.Quoin Pharmaceuticals legt Termin für Aktionärsversammlung 2024 fest3
30.09.Quoin Pharmaceuticals sets date for 2024 shareholder meeting1
30.09.Quoin Pharmaceuticals, Ltd. - 8-K, Current Report2
10.09.Pre-market Movers: Silexion Therapeutics, Quoin Pharmaceuticals, Actelis Networks, Mission Produce, Singularity Future Technology853REDWOOD SHORES (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 07.15 A.M. ET).In the Green Silexion Therapeutics Corp (SLXN) is up over...
► Artikel lesen
09.09.Quoin Pharmaceuticals announces insider share purchases3
09.09.Quoin Pharmaceuticals, Inc.: Quoin Pharmaceuticals Announces Insider Share Purchases by Co-Founders CEO and COO1
05.09.Quoin Pharmaceuticals COO acquires $28,737 in company shares5
05.09.Quoin Pharmaceuticals CEO acquires shares worth over $28k1
08.08.Quoin Pharmaceuticals, Ltd. - 10-Q, Quarterly Report1
08.08.QNRX stock plunges to 52-week low, hitting $0.512
08.08.Quoin Pharmaceuticals reports Q2 results1
08.08.Quoin Pharmaceuticals, Inc.: Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2024 Financial Results159Quoin Broadens Product Portfolio through Research Agreement with University College Cork, Ireland Company Expands On-going Clinical Trials in Netherton Syndrome to Include International Sites Announced...
► Artikel lesen
06.08.Quoin Pharmaceuticals, Inc.: Quoin Pharmaceuticals to Initiate Clinical Study for Peeling Skin Syndrome93Peeling Skin Syndrome is a rare autosomal disease with no approved treatment or cure Initial clinical site and pediatric patient identified in New Zealand Company actively evaluating opening additional...
► Artikel lesen
01.08.Quoin Pharmaceuticals, Inc.: Quoin Pharmaceuticals to Announce Second Quarter 2024 Financial Results on Thursday, August 8, 20241
25.06.Quoin Pharmaceuticals, Inc.: Quoin Pharmaceuticals to Sponsor the Foundation for Ichthyosis & Related Skin Types (FIRST) 2024 National Conference2
12.06.Quoin Pharmaceuticals, Inc.: Quoin Pharmaceuticals Announces Signing of Research Agreement with University College Cork (UCC), Ireland1
Seite:  Weiter >>
26 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1